FDA withdraws approval Oxandrin (Oxandrolone), Gemini Laboratories’ anabolic steroid indicated for weight gain after extensive surgery, relief of bone pain due to osteoporosis as there was no evidence of efficacy for the tablets and potential problems with the drug are sufficiently serious Read More..